Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia

NCT03594838

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Imedi Harm Reduction Site Batumi, Georgia
  • Step to the Future Harm Reduction Site Gori, Georgia
  • New Way Harm Reduction Site Kutaisi, Georgia
  • New Vector Harm Reduction Site Rustavi, Georgia
View Trial Details
Completed

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

NCT02641158

Conditions
AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +26 more
Locations
  • University Hospital at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • Jackson Health System Adult HIV Outpatient Clinics / University of Miami Miami, Florida, United States
  • Grady Memorial Hospital / Ponce de Leon Center Atlanta, Georgia, United States
View Trial Details
Completed

Patient-Centered Care and Asian Americans

NCT02139722

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • Zuckerberg San Francisco General San Francisco, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Completed

Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults

NCT03393754

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • Accel Research Sites Birmingham, Alabama, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • Avail Clinical Research DeLand, Florida, United States
  • Suncoast Research Group Miami, Florida, United States
View all 28 locations
View Trial Details
Completed

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01453998

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

NCT01726439

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Chongqing, Chongqing Municipality, China
  • Local Institution Chongqing, Chongqing Municipality, China
  • Local Institution Fuzhou, Fujian, China
View all 54 locations
View Trial Details

Related conditions